FDA Inspection 1086346 — Vitalife Laboratories (A Div. Of Arch Pharmalabs Limited)
The FDA completed an inspection of Vitalife Laboratories (A Div. Of Arch Pharmalabs Limited) on March 4, 2019 in Gurugram. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 4, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gurugram (India)